Literature DB >> 12571182

Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l.

E C Larsen1, J Müller, C Rechnitzer, K Schmiegelow, A Nyboe Andersen.   

Abstract

BACKGROUND: Approximately 70% of children treated for cancer are cured, however the treatment often impairs reproductive function. The aim of the present study was to assess ovarian reserve in women with an apparently normal ovarian function, who were cured of cancer in childhood.
METHODS: Twenty-one female survivors with regular menstrual cycles and basal FSH <10 IU/l were included. The control group included 21 healthy age-matched regularly cycling women. On cycle day 2-5, ovarian volume and number of small antral follicles (2-5 mm) were evaluated with transvaginal ultrasonography. Repeated sonography, urinary LH testing, and endocrine assessments were performed during the actual cycle. Cycle length was calculated.
RESULTS: The female survivors had significantly smaller volume per ovary (4.9 versus 6.8 cm(3); P < 0.01), a lower number of small antral follicles per ovary (4.5 versus 8.0; P < 0.01), and lower total number of follicles per ovary (8 versus 11, P < 0.01). Hormonal profiles were similar, but the mean cycle length of the female survivors was significantly shorter than in the control group (28.3 versus 31.0 days; P < 0.05).
CONCLUSIONS: Childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l seem to have a diminished ovarian reserve. Consequently, they may have a shortened reproductive span and an early menopause.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571182     DOI: 10.1093/humrep/deg073

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

1.  Impact of cancer therapies on ovarian reserve.

Authors:  Clarisa R Gracia; Mary D Sammel; Ellen Freeman; Maureen Prewitt; Claire Carlson; Anushree Ray; Ashley Vance; Jill P Ginsberg
Journal:  Fertil Steril       Date:  2011-12-02       Impact factor: 7.329

2.  Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women.

Authors:  Muhammad Faisal Aslam; Zaher O Merhi; Safaa Ahmed; Oumar Kuzbari; David B Seifer; Howard Minkoff
Journal:  Fertil Steril       Date:  2011-04       Impact factor: 7.329

3.  The psychosocial impact of interrupted childbearing in long-term female cancer survivors.

Authors:  Andrea L Canada; Leslie R Schover
Journal:  Psychooncology       Date:  2010-12-02       Impact factor: 3.894

4.  National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.

Authors:  Michael A Pulsipher; Roderick Skinner; George B McDonald; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Clarisa Gracia; Anna Petryk; Smita Bhatia; Nancy Bunin; Michael L Nieder; Christopher C Dvorak; Lillian Sung; Jean E Sanders; Joanne Kurtzberg; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2012-01-14       Impact factor: 5.742

Review 5.  Reproductive health after cancer.

Authors:  Clarisa R Gracia
Journal:  Cancer Treat Res       Date:  2010

Review 6.  Vitrification of embryos and oocytes for fertility preservation in cancer patients.

Authors:  Keiichi Kato
Journal:  Reprod Med Biol       Date:  2016-02-29

7.  Menstrual restoration in severe panhypopituitarism many years after cranial irradiation for suprasellar germinoma.

Authors:  Masanobu Ito; Ichiro Iwamoto; Hirofumi Hirano; Tsutomu Douchi
Journal:  Reprod Med Biol       Date:  2014-11-29

Review 8.  A changing perspective: improving access to fertility preservation.

Authors:  Joseph M Letourneau; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Nat Rev Clin Oncol       Date:  2010-08-24       Impact factor: 66.675

9.  An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety.

Authors:  J P Ginsberg; C A Carlson; K Lin; W L Hobbie; E Wigo; X Wu; R L Brinster; T F Kolon
Journal:  Hum Reprod       Date:  2009-10-27       Impact factor: 6.918

10.  Fertility preservation in reproductive-age women facing gonadotoxic treatments.

Authors:  J Roberts; R Ronn; N Tallon; H Holzer
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.